Doctors on RESPeRATE

"My patients thank me for recommending RESPeRATE and see real results"

- Dr. Rowena Sobczyk, Family Physician, Author of the book "My Body, My Health"
Atlanta, Georgia
Watch Video

 
"RESPeRATE allows my patients to have more of a role in their care."

- Dr. Joseph Marek, Midwest Heart Specialists
Downers Grove, IIlinois
Watch Video


"Our clinical study concluded that RESPeRATE is easy to use, did not have any side effects & delivered a significant blood pressure reduction."
- Dr. William Elliott, Rush University
Chicago, Illinois
Watch Video


Intercure

Press Releases Archive

2005 Press Releases

Non-drug Hypertension Treatment Device Presented at the British Hypertension Society Annual Meeting
Sep 27, 2005
White-Coat Effect is Virtually Eliminated Using a Non-drug Hypertension Treatment Device
May 16, 2005
InterCure Raises $3 Million in First Closing of Series C Financing Led By Major Japanese Venture Capital Firm
April 13, 2005
Frost & Sullivan Recognizes InterCure for Hypertension Treatment Technology Innovation
March 16, 2005
2004 Press Releases

Interactive Breathing Device Found Effective in Lowering High Systolic Blood Pressure
October 12, 2004
Non-Drug Treatment Device Delivers Sustained Blood Pressure Reductions Within 3-4 Weeks in the Home Setting
April 21, 2004
Korean FDA Approves Breakthrough Therapeutic Breathing Device To Lower Blood Pressure
April 7, 2004
2003 Press Releases

Respiratory-Pacing Device Found Beneficial in Heart Failure
Sept. 22, 2003
Non-drug treatment for hypertension found effective in hard-to-control refractory hypertensives
June 30, 2003
Non-drug, treatment for hypertension gets further physiological backing in American Heart Association's textbook
May 7, 2003
Il Yang Pharm Named As Intercure's Exclusive Distributor In Korea
February 4, 2003
2002 Press Releases

InterCure Appoints Exclusive Distributor In Israel
November 26, 2002
FDA Clears Breakthrough Therapeutic Breathing Device To Lower Blood Pressure
July 17, 2002
Positive Trial Results Provide Additional Support For RESPERATE™, New Non-Drug Treatment For High Blood Pressure
May 15 , 2002
2001 Press Releases

Italian Study Further Validates Use of RESPeRATE™ For Adjunctive Treatment of Hypertension
November 12 , 2001
InterCure Raises $4.5 Million in Second Round Financing Led by Medica Venture Partners
October 29, 2001
Michael Weber M.D., American Society of Hypertensions' Immediate Past President Joins InterCure Scientific Advisory Board
October 2 , 2001
InterCure Scientific Advisory Board Convenes to Review Company's RESPeRATE Medical Device for Hypertension
July 23, 2001
InterCure Names Paul Sheils, Former CEO of Medscape, As CEO to Head Medical Technology Innovator
May 14, 2001
2000 Press Releases

First Prescription-Only, Non-Drug Option for High-Blood Pressure Now Available
December 21, 2000
InterCure Selects SoftWatch SRS 2.0 Platform to Power RESPeRATE™ for Lower Blood Pressure
August 9, 2000
InterCure Selects SoftWatch SRS 2.0 Platform to Power RESPeRATE™ for Lower Blood Pressure
August 9, 2000
InterCure Receives Market Clearance for RESPeRATE™ Device as Adjunctive Treatment for High Blood Pressure
May 18, 2000
InterCure Receives a $5.4 Million Investment From Manhattan-Based VC Funds...
March 29, 2000




Archives
Current Releases
Press Releases 2005
Press Releases 2004
Press Releases 2003
Press Releases 2002
Press Releases 2001
Press Releases 2000

Next: Investor Relations Next

Please Note: RESPeRATE should only be used as a part of an overall health program for achieving goal blood pressure, as recommended by a doctor. RESPeRATE can be safely used in conjunction with medications and lifestyle modifications such as diet and exercise.

  • © 1998-2008 InterCure. All Rights Reserved
101